Aspen Pharmacare Profit Margin 2017-2023 | APNHY

Current and historical gross margin, operating margin and net profit margin for Aspen Pharmacare (APNHY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Aspen Pharmacare net profit margin as of June 30, 2023 is 0%.
Aspen Pharmacare Annual Profit Margins
Aspen Pharmacare Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.900B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.835B 18.71
BridgeBio Pharma (BBIO) United States $4.401B 0.00
Bausch Health Cos (BHC) Canada $3.128B 2.44
Amphastar Pharmaceuticals (AMPH) United States $2.004B 13.71
Supernus Pharmaceuticals (SUPN) United States $1.656B 0.00
Taysha Gene Therapies (TSHA) United States $0.439B 0.00
Generation Bio (GBIO) United States $0.199B 0.00
Assembly Biosciences (ASMB) United States $0.074B 0.00
Personalis (PSNL) United States $0.066B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00